Biomarkers in Transplant Recipients to Improve Outcomes

Conditions

• Bone Marrow Transplantation
• Solid Organ Transplantation

Eligibility Criteria

Sex

ALL

Age

N/A - N/A

Healthy Volunteers

Not accepted

Study Details

The objective of this study is to evaluate whether certain proteins, expressed in biological tissues can indict a better understanding of the effect of drugs that are used to treat rejection, and of processes leading to rejection and rejection-free outcomes.

Key Dates

Start date

Mar 31, 2005

Status verified

Sep 2025

Primary completion

Mar 31, 2030

Completion

Mar 31, 2030

Study Design

Enrollment

1,200 participants (estimated)

Primary Outcome Measure

Rejection [ Time Frame: 90 day post transplantation (clinical severity) ]

Central Contacts

• Morgan L Paul, BSN
  412-692-8472
  [email protected]
• Daniel Pieratt, MPA
  412-692-6692
  [email protected]

Locations (1)

Find similar trials in Pittsburgh, PA